MMP2 and melanoma: The authors showed that nontoxic physiologic doses of JaZ-30 reduced the invasive properties of highly metastatic melanoma cells by 40% through selective inhibition of MMP-2 catalytic activity through coordination with a zinc atom in the enzyme’s active center and mediated suppression of VEGF secretion [130].